The Role of the Clinical Pharmacist in the Management of Multiple Myeloma
The Role of the Clinical Pharmacist in the Management of Multiple Myeloma is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.
Release date: 05/22/2023
Expiration date: 05/22/2024
Educational Objectives:
After participating in this educational activity, learners should be better able to:
• Evaluate the role of newly approved agents and emerging therapies in treating newly diagnosed multiple myeloma (NDMM) as well as relapsed/refractory multiple myeloma (RRMM)
• Review clinical guidelines and expert insights in RRMM management
• Recognize and mitigate toxicities associated with newly approved agents
• Discuss the role of the pharmacists within the patient care team
• Develop a patient communication strategy that addresses potential toxicities to mitigate the risk of developing severe complications
Additional details will be posted as soon as information is available.